DE3681398D1 - Verfahren zur herstellung von insulinaehnlichem wachstumsfaktor i (igf-i) und plasmid zu dessen herstellung. - Google Patents

Verfahren zur herstellung von insulinaehnlichem wachstumsfaktor i (igf-i) und plasmid zu dessen herstellung.

Info

Publication number: DE3681398D1
Authority: DE; Germany
Prior art keywords: production; igf; fused; plasmide; insuline
Prior art date: 1985-10-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE8686114321T

Other languages

English (en)

Inventor

Ikuo Ueda

Mineo Niwa

Susumu Satoh

Yoshimasa Saitoh

Chihiro Kusunoki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Fujisawa Pharmaceutical Co Ltd

Original Assignee

Fujisawa Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-10-21

Filing date

1986-10-16

Publication date

1991-10-17

1985-10-21 Priority claimed from GB858525929A external-priority patent/GB8525929D0/en

1986-07-14 Priority claimed from GB868617073A external-priority patent/GB8617073D0/en

1986-10-16 Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd

1991-10-17 Application granted granted Critical

1991-10-17 Publication of DE3681398D1 publication Critical patent/DE3681398D1/de

2006-10-17 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Endocrinology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

DE8686114321T 1985-10-21 1986-10-16 Verfahren zur herstellung von insulinaehnlichem wachstumsfaktor i (igf-i) und plasmid zu dessen herstellung. Expired - Fee Related DE3681398D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB858525929A GB8525929D0 (en)	1985-10-21	1985-10-21	Production of insulin-like growth factor
GB868617073A GB8617073D0 (en)	1986-07-14	1986-07-14	Insulin-like growth factor i

Publications (1)

Publication Number	Publication Date
DE3681398D1 true DE3681398D1 (de)	1991-10-17

Family

ID=26289914

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8686114321T Expired - Fee Related DE3681398D1 (de)	1985-10-21	1986-10-16	Verfahren zur herstellung von insulinaehnlichem wachstumsfaktor i (igf-i) und plasmid zu dessen herstellung.

Country Status (10)

Country	Link
EP (1)	EP0219814B1 (de)
JP (1)	JPH07114702B2 (de)
KR (1)	KR880001813A (de)
AT (1)	ATE67243T1 (de)
CA (1)	CA1297814C (de)
DE (1)	DE3681398D1 (de)
DK (1)	DK502786A (de)
ES (1)	ES2029785T3 (de)
GR (1)	GR3002696T3 (de)
IL (1)	IL80376A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988005078A1 (en) *	1986-12-31	1988-07-14	Lucky, Ltd.	Method for the production of bovine growth hormone using a synthetic gene
US7049102B1 (en)	1989-09-22	2006-05-23	Board Of Trustees Of Leland Stanford University	Multi-gene expression profile
KR920003787B1 (ko) *	1990-03-05	1992-05-14	한국과학기술 연구원	신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
JP2574549B2 (ja) *	1991-03-08	1997-01-22	萩原義秀	新規プラスミド
US5288931A (en) *	1991-12-06	1994-02-22	Genentech, Inc.	Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) *	1993-08-20	1997-09-02	Genentech, Inc.	Refolding of misfolded insulin-like growth factor-I
EP0779927A1 (de) *	1994-09-08	1997-06-25	Chiron Corporation	Methode zur gesteigerten herstellung von insulin-ähnlichem wachstumsfaktor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0561137B1 (de) *	1983-04-25	2002-07-03	Chiron Corporation	Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren
IL71991A (en) *	1983-06-06	1994-05-30	Genentech Inc	Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
SE8303626D0 (sv) *	1983-06-23	1983-06-23	Kabigen Ab	A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
WO1985000831A1 (en) *	1983-08-10	1985-02-28	Amgen	Microbial expression of insulin-like growth factor
HU194307B (en) *	1983-09-16	1988-01-28	Richter Gedeon Vegyeszet	Process for producing plasmidvectors of high copy number
DK108685A (da) *	1984-03-19	1985-09-20	Fujisawa Pharmaceutical Co	Vaekstfaktor i

1986
- 1986-10-16 AT AT86114321T patent/ATE67243T1/de not_active IP Right Cessation
- 1986-10-16 DE DE8686114321T patent/DE3681398D1/de not_active Expired - Fee Related
- 1986-10-16 JP JP61246740A patent/JPH07114702B2/ja not_active Expired - Fee Related
- 1986-10-16 EP EP86114321A patent/EP0219814B1/de not_active Expired - Lifetime
- 1986-10-16 ES ES198686114321T patent/ES2029785T3/es not_active Expired - Lifetime
- 1986-10-20 DK DK502786A patent/DK502786A/da unknown
- 1986-10-21 CA CA000520933A patent/CA1297814C/en not_active Expired - Fee Related
- 1986-10-21 IL IL80376A patent/IL80376A0/xx unknown
- 1986-10-24 KR KR1019860008945A patent/KR880001813A/ko not_active Application Discontinuation
1991
- 1991-09-12 GR GR91401142T patent/GR3002696T3/el unknown

Also Published As

Publication number	Publication date
ATE67243T1 (de)	1991-09-15
KR880001813A (ko)	1988-04-27
JPH07114702B2 (ja)	1995-12-13
IL80376A0 (en)	1987-01-30
EP0219814A1 (de)	1987-04-29
CA1297814C (en)	1992-03-24
DK502786A (da)	1987-04-22
GR3002696T3 (en)	1993-01-25
ES2029785T3 (es)	1992-10-01
DK502786D0 (da)	1986-10-20
JPS62175192A (ja)	1987-07-31
EP0219814B1 (de)	1991-09-11

Similar Documents

Publication	Publication Date	Title
ATE78868T1 (de)	1992-08-15	Alkalische protease, verfahren zur herstellung von hybridvektoren und genetisch transformierte mikroorganismen.
ATE213020T1 (de)	2002-02-15	Klonierung und expression von biologisch aktiver alpha-galaktosidase a
EP0123811A3 (en)	1986-03-26	The use of the gal 1 yeast promoter
DE3379591D1 (en)	1989-05-18	Microbially prepared interferon alpha2(arg), dna sequence coding for said interferon, microorganisms containing this genetic information and process for their production
ATE90944T1 (de)	1993-07-15	Fuer ein hirudinaehnliches protein kodierende dns- sequenz und verfahren zur herstellung eines solchen proteins.
AU588793B2 (en)	1989-09-28	Method of expressing alpha-1-antitrypsin in bacteria
DE3681398D1 (de)	1991-10-17	Verfahren zur herstellung von insulinaehnlichem wachstumsfaktor i (igf-i) und plasmid zu dessen herstellung.
DE69739013D1 (de)	2008-11-13	Verfahren zur Herstellung sekretorischer KEX2-Derivate
ATE16943T1 (de)	1985-12-15	Rekombinanter bakteriophage fuer heterologe klonierung von bazillus-mikroorganismen und verfahren zu seiner herstellung.
SE8100241L (sv)	1981-07-20	Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos proinsulinet av primater, dna och plasmider, vilka kodierar for denna sekvens mikroorganismer, som innehaller dessa genetiska informationer, ...
ATE2340T1 (de)	1983-02-15	Bestaendige plasmide mit hoher kopienanzahl, ihre herstellung und verwendung bei der proteinherstellung.
AU6698090A (en)	1991-06-06	Bacterial collagenase gene
DE3677421D1 (de)	1991-03-14	Mikrobiologisches verfahren zur herstellung von menschlichem lysozym.
ATE60359T1 (de)	1991-02-15	Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
DE69132342D1 (de)	2000-09-07	Verwendung von autologen Promotoren zur Expression von Genprodukten in Bordetella
ATE78870T1 (de)	1992-08-15	Verfahren zur herstellung von neutraler protease.
ATE122097T1 (de)	1995-05-15	Expressionsvektor und verfahren zur regulierbaren herstellung von proteinen in eukaryonten.
ES8607390A1 (es)	1986-06-01	Metodo de detectar acidos nucleicos.
ATE90387T1 (de)	1993-06-15	Plasmide, verfahren zu ihrer herstellung, sie enthaltende mikroorganismen und methoden zur extrazellulaeren herstellung von xylanase durch zuechten dieser mikroorganismen.
ATE127154T1 (de)	1995-09-15	Verfahren zur herstellung der afl ii restriktionsendonuklease.

Legal Events

Date	Code	Title	Description
1992-10-08	8364	No opposition during term of opposition
1998-11-12	8339	Ceased/non-payment of the annual fee